The Management Board of Nestmedic S.A. with its registered office in Warsaw (hereinafter the “Company”, the “Issuer”) hereby submits, attached hereto, the separate and consolidated quarterly report for Q4 2022.
Legal basis:
§ 5 sec. 1 item 1 of Appendix No. 3 to the Rules of the Alternative Trading System “Current and Periodic Information Provided in the Alternative Trading System on the NewConnect Market”
Jacek Gnich – President of the Management Board
Izabela Robaczewska – Commercial Proxy
